Clinical Trial

Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma

Name: Clofarabine Therapy in Locally Advanced or Metastatic Urothelial Carcinoma — clinical trial record (NCT07034053)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This phase 1/2 study will evaluate the maximum tolerated dose, efficacy, and safety of clofarabine in patients with advanced or metastatic urothelial cancer.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-13.

Trial Details

NCT Number	NCT07034053
Lead Sponsor	Ekaterina Laukhtina
Conditions	Advanced Urothelial Carcinoma, Metastatic Urothelial Cancer
Enrollment	50 participants
Start Date	2023-10-24
Primary Completion	2028-11 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2025-06-26